Soni A, Sampliner RE, Sonnenberg A. Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? Am J Gastroenterol 2000 Aug;95(8):2086-93 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/10950062.
Compare quality appraisals for each clinical question
- Is surveillance cost-effective for follow-up of patients with BO?
- For which populations is screening for BO cost-effective?